Peripheral Neuropathy News and Research

RSS
Peripheral neuropathy describes damage to the peripheral nervous system, which transmits information from the brain and spinal cord to every other part of the body.

More than 100 types of peripheral neuropathy have been identified, each with its own characteristic set of symptoms, pattern of development, and prognosis. Impaired function and symptoms depend on the type of nerves -- motor, sensory, or autonomic -- that are damaged. Some people may experience temporary numbness, tingling, and pricking sensations, sensitivity to touch, or muscle weakness. Others may suffer more extreme symptoms, including burning pain (especially at night), muscle wasting, paralysis, or organ or gland dysfunction. Peripheral neuropathy may be either inherited or acquired. Causes of acquired peripheral neuropathy include physical injury (trauma) to a nerve, tumors, toxins, autoimmune responses, nutritional deficiencies, alcoholism, and vascular and metabolic disorders. Acquired peripheral neuropathies are caused by systemic disease, trauma from external agents, or infections or autoimmune disorders affecting nerve tissue. Inherited forms of peripheral neuropathy are caused by inborn mistakes in the genetic code or by new genetic mutations.
Genta commences tesetaxel Phase 2b clinical trial as 1st-line chemotherapy for metastatic breast cancer

Genta commences tesetaxel Phase 2b clinical trial as 1st-line chemotherapy for metastatic breast cancer

EpiCept third quarter net loss decreases to $3.2 million

EpiCept third quarter net loss decreases to $3.2 million

XenoPort third quarter net loss decreases to $19.9 million

XenoPort third quarter net loss decreases to $19.9 million

SGN-35 drug reduces tumor growth in Hodgkin's lymphoma

SGN-35 drug reduces tumor growth in Hodgkin's lymphoma

FDA approves Cymbalta for treatment of chronic musculoskeletal pain

FDA approves Cymbalta for treatment of chronic musculoskeletal pain

New England Journal of Medicine publishes brentuximab vedotin Phase I clinical trial data

New England Journal of Medicine publishes brentuximab vedotin Phase I clinical trial data

New antibody with SGN-35 drug produces remission in Hodgkin lymphoma

New antibody with SGN-35 drug produces remission in Hodgkin lymphoma

VA begins distributing disability benefits to Vietnam Veterans exposed to Agent Orange

VA begins distributing disability benefits to Vietnam Veterans exposed to Agent Orange

EMA issues Scientific Advice to Genta's clinical development plan for tesetaxel in patients with gastric cancer

EMA issues Scientific Advice to Genta's clinical development plan for tesetaxel in patients with gastric cancer

Pfizer announces approval of Lyrica capsules for peripheral neuropathic pain

Pfizer announces approval of Lyrica capsules for peripheral neuropathic pain

Burn injuries in children show vitamin E depletion in fat tissues

Burn injuries in children show vitamin E depletion in fat tissues

UCB presents P3, P4 clinical trial data for Crohn's disease at ACG Scientific Meeting

UCB presents P3, P4 clinical trial data for Crohn's disease at ACG Scientific Meeting

ACG meeting to exhibit Cimzia data for Crohn's disease treatment

ACG meeting to exhibit Cimzia data for Crohn's disease treatment

Genta announces EMA Orphan Drug designation for tesetaxel

Genta announces EMA Orphan Drug designation for tesetaxel

CTTC, Spero enter sales agreement for Calmare medical devices

CTTC, Spero enter sales agreement for Calmare medical devices

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Sanofi-aventis publishes Phase III TROPIC study data in The Lancet article

Sanofi-aventis publishes Phase III TROPIC study data in The Lancet article

Genta commences new tesetaxel Phase 2 clinical trial in advanced bladder cancer

Genta commences new tesetaxel Phase 2 clinical trial in advanced bladder cancer

Researchers develop KU-32 drug to prevent diabetic peripheral neuropathy

Researchers develop KU-32 drug to prevent diabetic peripheral neuropathy

Mayo Clinic opens newly expanded neurophysiology laboratory at Florida campus

Mayo Clinic opens newly expanded neurophysiology laboratory at Florida campus